The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase II trial of pazopanib (P) in patients with angiosarcoma (AS).
 
Margaret von Mehren
Consulting or Advisory Role - Blueprint Medicines; CytRx Corporation; deciphera; Janssen Oncology
Research Funding - ArQule
Travel, Accommodations, Expenses - Arog
Other Relationship - NCCN
 
Samuel Litwin
No Relationships to Disclose
 
Vinod Ravi
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Scott Schuetze
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - AB Science (Inst); Adaptimmune (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); Blueprint Medicines (Inst); CytRx Corporation (Inst); Janssen Research & Development (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Blueprint Medicines
 
Sujana Movva
Consulting or Advisory Role - Genmab
Research Funding - Novartis (Inst); Takeda (Inst)
 
Mark Agulnik
Consulting or Advisory Role - Bayer; Immune Design; Lilly; Novartis
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Eisai; Janssen
 
Andrew S. Kraft
No Relationships to Disclose
 
Eric Daniel Tetzlaff
Consulting or Advisory Role - Blueprint Medicines; Novartis
 
Neeta Somaiah
Consulting or Advisory Role - Bayer; Deciphera; Immune Design
Research Funding - MedImmune